Publications by authors named "Robert Mader"

Claim this Profile
C
Cross-neutralizing activity of the chikungunya vaccine VLA1553 against three prevalent chikungunya lineages.
Karin Kosulin, Trevor L Brasel, Jeanon Smith, Maricela Torres, Annegret Bitzer, Robert Mader

Emerg Microbes Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil.
Vera Buerger, Andrea Pfeiffer, Petra Schoengrundner, Jutta Seebacher, Romana Hochreiter, Robert Mader

Lancet Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of new approach methodologies for nonclinical safety assessment of drug candidates.
Mario Beilmann, Karissa Adkins, Harrie C M Boonen, Philip Hewitt, Wenyue Hu, Robert Mader

Nat Rev Drug Discov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development.
Leopold Koenig, Laurent Juglair, Thi Phuong Tao, Susanne Fischer, Inga Clausen, Robert Mader

Commun Biol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical B cell depletion and safety profile of a brain-shuttled crystallizable fragment-silenced CD20 antibody.
Vanessa L Schumacher, Solen Pichereau, Juliana Bessa, Juergen Bachl, Sylvia Herter, Robert Mader

Clin Transl Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents.
Vera Buerger, Sandra Hadl, Martina Schneider, Michaela Schaden, Romana Hochreiter, Robert Mader

Lancet Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study.
Robert McMahon, Sebastian Toepfer, Natascha Sattler, Martina Schneider, Marivic Narciso-Abraham, Robert Mader

Lancet Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults†.
Robert McMahon, Ulrike Fuchs, Martina Schneider, Sandra Hadl, Romana Hochreiter, Robert Mader

J Travel Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10 years survival.
Vilas Wagh, Filomain Nguemo, Zlata Kiseleva, Robert M Mader, Juergen Hescheler

ESC Heart Fail· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer.
Thomas Bartl, Christoph Grimm, Robert M Mader, Christoph Zielinski, Gerald Prager

J Pers Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo.
Paul Strasser, Bianca Montsch, Silvia Weiss, Haider Sami, Christoph Kugler, Robert Mader

Small· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial.
Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl, Robert McMahon, Sebastian Toepfer, Robert Mader

Lancet· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signs and signals limiting myocardial damage using PICSO: a scoping review decoding paradigm shifts toward a new encounter.
Werner Mohl, Zlata Kiseleva, Alem Jusic, Matthäus Bruckner, Robert M Mader

Front Cardiovasc Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Medicine in Inflammatory Bowel Diseases: Challenges and Considerations for the Path Forward.
Amanda Ricciuto, Ingrid Rauter, Dermot P B McGovern, Robert M Mader, Walter Reinisch

Gastroenterology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors.
Hossein Taghizadeh, Agnieszka Maj-Hes, Gerald W Prager, Leonhard Müllauer, Robert M Mader

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9.
Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer, Robert M Stoekenbroek, Gilles Lambert, Robert M Mader

Eur J Clin Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake .
Hemma Schueffl, Sarah Theiner, Gerrit Hermann, Josef Mayr, Philipp Fronik, Robert M Mader

Chem Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue distribution of epirubicin after severe extravasation in humans.
Jakob Nedomansky, Werner Haslik, Ursula Pluschnig, Christoph Kornauth, Christine Deutschmann, Robert M Mader

Cancer Chemother Pharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecularly guided treatment of metastatic parotid gland carcinoma in adults.
Hossein Taghizadeh, Leonhard Müllauer, Robert M Mader, Thorsten Füreder, Gerald W Prager

Wien Klin Wochenschr· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Medicine for the Management of Therapy Refractory Colorectal Cancer.
Hossein Taghizadeh, Robert M Mader, Leonhard Müllauer, Friedrich Erhart, Alexandra Kautzky-Willer

J Pers Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers.
Hossein Taghizadeh, Robert M Mader, Leonhard Müllauer, Thorsten Fuereder, Alexandra Kautzky-Willer

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI.
Hossein Taghizadeh, Matthias Unseld, Martina Spalt, Robert M Mader, Leonhard Müllauer

J Pers Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.
Hossein Taghizadeh, Robert M Mader, Leonhard Müllauer, Stefanie Aust, Stephan Polterauer

Oncologist· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.
Hossein Taghizadeh, Sabine Zöchbauer-Müller, Robert M Mader, Leonhard Müllauer, Thomas Klikovits

Thorac Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applied precision medicine in metastatic pancreatic ductal adenocarcinoma.
Hossein Taghizadeh, Leonhard Müllauer, Robert M Mader, Martin Schindl, Gerald W Prager

Ther Adv Med Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis